Distribution of myeloid dendritic cells and plasmacytoid dendritic cells in the synovial tissues of rheumatoid arthritis. 2008

Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
Department of Orthopaedic Surgery, Yamagata University School of Medicine, and Yamagata Saisei Hospital, Yamagata, Japan. takakubo-y@med.id.yamagata-u.ac.jp

OBJECTIVE To examine the precise tissue distribution of dendritic cells (DC) and indoleamine 2,3-dioxygenase (IDO)-expressing cells in synovial tissue and synovial fluid (SF) from patients with rheumatoid arthritis (RA) and osteoarthritis (OA). METHODS Synovial tissues from 30 patients with RA and 7 with OA were immunohistochemically stained for DC markers. The examined areas were classified into 5 categories based on pathobiological staging and histopathological grading systems. Myeloid DC (mDC) and plasmacytoid DC (pDC) were isolated using positive and negative magnetic sorting systems, respectively, from SF samples (7 patients with RA and 4 with OA) and synovial tissues (3 RA, 4 OA). RESULTS mDC were mainly observed in lymphoid aggregations. pDC were scattered around perivenular infiltration areas, and small and large lymphoid aggregations in RA. The mDC/pDC ratio increased significantly, with higher grading in RA SF tissues compared to OA synovial tissues (p<0.05). IDO-immunoreactivity was detected in pDC by serial sectioning and staining of RA synovial tissues. CONCLUSIONS Our results indicate that mature mDC play a central role in the RA inflammatory process. Although there were fewer pDC than mDC, the presence of IDO-positive pDC suggests a possible tolerance mechanism in RA synovial tissues. However, it is probably modest due to the marked inflammation in RA, in which mDC are dominant.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
April 2024, ACR open rheumatology,
Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
January 2005, Arthritis research & therapy,
Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
April 2004, Rheumatology (Oxford, England),
Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
January 1988, Scandinavian journal of rheumatology. Supplement,
Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
May 2009, Journal of clinical and experimental hematopathology : JCEH,
Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
April 2018, Trends in molecular medicine,
Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
July 2017, Rheumatology international,
Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
January 2009, Arthritis research & therapy,
Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
January 2019, Medical hypotheses,
Yuya Takakubo, and Michiaki Takagi, and Kunihiko Maeda, and Yasunobu Tamaki, and Akiko Sasaki, and Tamon Asano, and Shigenobu Fukushima, and Yoshiro Kiyoshige, and Hiroshi Orui, and Toshihiko Ogino, and Mitsunori Yamakawa
June 2003, The Journal of pathology,
Copied contents to your clipboard!